Reuters
Published: 06 Jan 2021 02:40 PM BdST
Updated: 06 Jan 2021 02:40 PM BdST Carmat Chief Executive Officer Stephane Piat holds an artificial heart as he poses after the company s news conference in Paris, France, Feb 14, 2017. REUTERS
French artificial heart maker Carmat said it was preparing to start selling its products in the second quarter of this year, in a European market which could have at least 2,000 patients annually, sending its shares higher. );
}
Carmat said its artificial heart would be marketed under the brand name of Aeson . Aeson would be launched commercially in Germany in the second quarter, while the French market would be targeted around the same time.
Article content
PARIS French artificial heart maker Carmat said on Wednesday that it was preparing for the commercial launch of its products in the second quarter of this year, in a European market which could have at least 2,000 patients annually.
Carmat said its artificial heart would be marketed under the brand name of “Aeson.” Aeson would be launched commercially in Germany in the second quarter, while the French market would be targeted around the same time.
We apologize, but this video has failed to load.
Try refreshing your browser, or French artificial heart maker Carmat prepares for commercial launch in Q2 Back to video
Health: Artificial heartmaker Carmat to start sales after EU approval gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.